CRISPR And CRISPR-Associated (Cas) Genes Market


Report ID : RNR-77312 Category : Biotechnology Published Date : jan 2017
Publisher : S&P Consulting Pages : 129 Format : PDF
Notes:
Production, means the output of CRISPR And CRISPR-Associated (Cas) Genes
Revenue, means the sales value of CRISPR And CRISPR-Associated (Cas) Genes

This report studies CRISPR And CRISPR-Associated (Cas) Genes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Caribou Biosciences
    Addgene
    CRISPR THERAPEUTICS
    Merck KGaA
    Mirus Bio LLC
    Editas Medicine
    Takara Bio USA
    Thermo Fisher Scientific
    Horizon Discovery Group
    Intellia Therapeutics
    GE Healthcare Dharmacon

By types, the market can be split into
    Vector-Based
    DNA-Free Cas

By Application, the market can be split into
    Genome Engineering
    Disease Models
    Functional Genomics

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India
Global CRISPR And CRISPR-Associated (Cas) Genes Market Professional Survey Report 2017
1 Industry Overview of CRISPR And CRISPR-Associated (Cas) Genes
    1.1 Definition and Specifications of CRISPR And CRISPR-Associated (Cas) Genes
        1.1.1 Definition of CRISPR And CRISPR-Associated (Cas) Genes
        1.1.2 Specifications of CRISPR And CRISPR-Associated (Cas) Genes
    1.2 Classification of CRISPR And CRISPR-Associated (Cas) Genes
        1.2.1 Vector-Based
        1.2.2 DNA-Free Cas
    1.3 Applications of CRISPR And CRISPR-Associated (Cas) Genes
        1.3.1 Genome Engineering
        1.3.2 Disease Models
        1.3.3 Functional Genomics
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of CRISPR And CRISPR-Associated (Cas) Genes
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of CRISPR And CRISPR-Associated (Cas) Genes
    2.3 Manufacturing Process Analysis of CRISPR And CRISPR-Associated (Cas) Genes
    2.4 Industry Chain Structure of CRISPR And CRISPR-Associated (Cas) Genes

3 Technical Data and Manufacturing Plants Analysis of CRISPR And CRISPR-Associated (Cas) Genes
    3.1 Capacity and Commercial Production Date of Global CRISPR And CRISPR-Associated (Cas) Genes Major Manufacturers in 2015
    3.2 Manufacturing Plants Distribution of Global CRISPR And CRISPR-Associated (Cas) Genes Major Manufacturers in 2015
    3.3 R&D Status and Technology Source of Global CRISPR And CRISPR-Associated (Cas) Genes Major Manufacturers in 2015
    3.4 Raw Materials Sources Analysis of Global CRISPR And CRISPR-Associated (Cas) Genes Major Manufacturers in 2015

4 Global CRISPR And CRISPR-Associated (Cas) Genes Overall Market Overview
    4.1 2012-2017 Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017 Global CRISPR And CRISPR-Associated (Cas) Genes Capacity and Growth Rate Analysis
        4.2.2 2015 CRISPR And CRISPR-Associated (Cas) Genes Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate Analysis
        4.3.2 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Price
        4.4.2 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales Price Analysis (Company Segment)

5 CRISPR And CRISPR-Associated (Cas) Genes Regional Market Analysis
    5.1 North America CRISPR And CRISPR-Associated (Cas) Genes Market Analysis
        5.1.1 North America CRISPR And CRISPR-Associated (Cas) Genes Market Overview
        5.1.2 North America 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Sales Price Analysis
        5.1.4 North America 2015 CRISPR And CRISPR-Associated (Cas) Genes Market Share Analysis
    5.2 China CRISPR And CRISPR-Associated (Cas) Genes Market Analysis
        5.2.1 China CRISPR And CRISPR-Associated (Cas) Genes Market Overview
        5.2.2 China 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Sales Price Analysis
        5.2.4 China 2015 CRISPR And CRISPR-Associated (Cas) Genes Market Share Analysis
    5.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Analysis
        5.3.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Overview
        5.3.2 Europe 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Sales Price Analysis
        5.3.4 Europe 2015 CRISPR And CRISPR-Associated (Cas) Genes Market Share Analysis
    5.4 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Market Analysis
        5.4.1 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Market Overview
        5.4.2 Southeast Asia 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Sales Price Analysis
        5.4.4 Southeast Asia 2015 CRISPR And CRISPR-Associated (Cas) Genes Market Share Analysis
    5.5 Japan CRISPR And CRISPR-Associated (Cas) Genes Market Analysis
        5.5.1 Japan CRISPR And CRISPR-Associated (Cas) Genes Market Overview
        5.5.2 Japan 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Sales Price Analysis
        5.5.4 Japan 2015 CRISPR And CRISPR-Associated (Cas) Genes Market Share Analysis
    5.6 India CRISPR And CRISPR-Associated (Cas) Genes Market Analysis
        5.6.1 India CRISPR And CRISPR-Associated (Cas) Genes Market Overview
        5.6.2 India 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Sales Price Analysis
        5.6.4 India 2015 CRISPR And CRISPR-Associated (Cas) Genes Market Share Analysis

6 Global 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Segment Market Analysis (by Type)
    6.1 Global 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Sales by Type
    6.2 Different Types of CRISPR And CRISPR-Associated (Cas) Genes Product Interview Price Analysis
    6.3 Different Types of CRISPR And CRISPR-Associated (Cas) Genes Product Driving Factors Analysis
        6.3.1 Vector-Based of CRISPR And CRISPR-Associated (Cas) Genes Growth Driving Factor Analysis
        6.3.2 DNA-Free Cas of CRISPR And CRISPR-Associated (Cas) Genes Growth Driving Factor Analysis

7 Global 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Segment Market Analysis (by Application)
    7.1 Global 2012-2017 CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
    7.2 Different Application of CRISPR And CRISPR-Associated (Cas) Genes Product Interview Price Analysis
    7.3 Different Application of CRISPR And CRISPR-Associated (Cas) Genes Product Driving Factors Analysis
        7.3.1 Genome Engineering of CRISPR And CRISPR-Associated (Cas) Genes Growth Driving Factor Analysis
        7.3.2 Disease Models of CRISPR And CRISPR-Associated (Cas) Genes Growth Driving Factor Analysis
        7.3.3 Functional Genomics of CRISPR And CRISPR-Associated (Cas) Genes Growth Driving Factor Analysis

8 Major Manufacturers Analysis of CRISPR And CRISPR-Associated (Cas) Genes
    8.1 Caribou Biosciences
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Vector-Based
            8.1.2.2 DNA-Free Cas
        8.1.3 Caribou Biosciences 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Caribou Biosciences 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.2 Addgene
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Vector-Based
            8.2.2.2 DNA-Free Cas
        8.2.3 Addgene 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Addgene 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.3 CRISPR THERAPEUTICS
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Vector-Based
            8.3.2.2 DNA-Free Cas
        8.3.3 CRISPR THERAPEUTICS 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 CRISPR THERAPEUTICS 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.4 Merck KGaA
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Vector-Based
            8.4.2.2 DNA-Free Cas
        8.4.3 Merck KGaA 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Merck KGaA 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.5 Mirus Bio LLC
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Vector-Based
            8.5.2.2 DNA-Free Cas
        8.5.3 Mirus Bio LLC 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Mirus Bio LLC 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.6 Editas Medicine
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Vector-Based
            8.6.2.2 DNA-Free Cas
        8.6.3 Editas Medicine 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Editas Medicine 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.7 Takara Bio USA
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Vector-Based
            8.7.2.2 DNA-Free Cas
        8.7.3 Takara Bio USA 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Takara Bio USA 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.8 Thermo Fisher Scientific
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Vector-Based
            8.8.2.2 DNA-Free Cas
        8.8.3 Thermo Fisher Scientific 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Thermo Fisher Scientific 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.9 Horizon Discovery Group
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Vector-Based
            8.9.2.2 DNA-Free Cas
        8.9.3 Horizon Discovery Group 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Horizon Discovery Group 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.10 Intellia Therapeutics
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Vector-Based
            8.10.2.2 DNA-Free Cas
        8.10.3 Intellia Therapeutics 2015 CRISPR And CRISPR-Associated (Cas) Genes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Intellia Therapeutics 2015 CRISPR And CRISPR-Associated (Cas) Genes Business Region Distribution Analysis
    8.11 GE Healthcare Dharmacon

9 Development Trend of Analysis of CRISPR And CRISPR-Associated (Cas) Genes Market
    9.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Trend Analysis
        9.1.1 Global 2017-2022 CRISPR And CRISPR-Associated (Cas) Genes Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 CRISPR And CRISPR-Associated (Cas) Genes Sales Price Forecast
    9.2 CRISPR And CRISPR-Associated (Cas) Genes Regional Market Trend
        9.2.1 North America 2017-2022 CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast
        9.2.2 China 2017-2022 CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast
        9.2.3 Europe 2017-2022 CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast
        9.2.5 Japan 2017-2022 CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast
        9.2.6 India 2017-2022 CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast
    9.3 CRISPR And CRISPR-Associated (Cas) Genes Market Trend (Product Type)
    9.4 CRISPR And CRISPR-Associated (Cas) Genes Market Trend (Application)

10 CRISPR And CRISPR-Associated (Cas) Genes Marketing Type Analysis
    10.1 CRISPR And CRISPR-Associated (Cas) Genes Regional Marketing Type Analysis
    10.2 CRISPR And CRISPR-Associated (Cas) Genes International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of CRISPR And CRISPR-Associated (Cas) Genes by Regions
    10.4 CRISPR And CRISPR-Associated (Cas) Genes Supply Chain Analysis

11 Consumers Analysis of CRISPR And CRISPR-Associated (Cas) Genes
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis